These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 29653646

  • 1. Changes in glomerular filtration rate and outcomes in patients with atrial fibrillation.
    Fauchier L, Bisson A, Clementy N, Vourc'h P, Angoulvant D, Babuty D, Halimi JM, Lip GYH.
    Am Heart J; 2018 Apr; 198():39-45. PubMed ID: 29653646
    [Abstract] [Full Text] [Related]

  • 2. A prospective study of estimated glomerular filtration rate and outcomes in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project.
    Banerjee A, Fauchier L, Vourc'h P, Andres CR, Taillandier S, Halimi JM, Lip GYH.
    Chest; 2014 Jun; 145(6):1370-1382. PubMed ID: 24356875
    [Abstract] [Full Text] [Related]

  • 3. Renal impairment and ischemic stroke risk assessment in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project.
    Banerjee A, Fauchier L, Vourc'h P, Andres CR, Taillandier S, Halimi JM, Lip GY.
    J Am Coll Cardiol; 2013 May 21; 61(20):2079-87. PubMed ID: 23524209
    [Abstract] [Full Text] [Related]

  • 4. Sequential changes in renal function and the risk of stroke and death in patients with atrial fibrillation.
    Guo Y, Wang H, Zhao X, Zhang Y, Zhang D, Ma J, Wang Y, Lip GY.
    Int J Cardiol; 2013 Oct 12; 168(5):4678-84. PubMed ID: 23972369
    [Abstract] [Full Text] [Related]

  • 5. Renal impairment in a "real-life" cohort of anticoagulated patients with atrial fibrillation (implications for thromboembolism and bleeding).
    Roldán V, Marín F, Fernández H, Manzano-Fernández S, Gallego P, Valdés M, Vicente V, Lip GY.
    Am J Cardiol; 2013 Apr 15; 111(8):1159-64. PubMed ID: 23337836
    [Abstract] [Full Text] [Related]

  • 6. Glomerular filtration rate: A prognostic marker in atrial fibrillation-A subanalysis of the AntiThrombotic Agents Atrial Fibrillation.
    Proietti R, Gonzini L, Pizzimenti G, Ledda A, Sanna P, AlTurki A, Russo V, Lencioni M, ATA-AF Investigators.
    Clin Cardiol; 2018 Dec 15; 41(12):1570-1577. PubMed ID: 30144119
    [Abstract] [Full Text] [Related]

  • 7. Renal Function and the Risk of Stroke and Bleeding in Patients With Atrial Fibrillation: An Observational Cohort Study.
    Bonde AN, Lip GY, Kamper AL, Fosbøl EL, Staerk L, Carlson N, Torp-Pedersen C, Gislason G, Olesen JB.
    Stroke; 2016 Nov 15; 47(11):2707-2713. PubMed ID: 27758943
    [Abstract] [Full Text] [Related]

  • 8. Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation.
    Gallego P, Roldán V, Torregrosa JM, Gálvez J, Valdés M, Vicente V, Marín F, Lip GY.
    Circ Arrhythm Electrophysiol; 2012 Apr 15; 5(2):312-8. PubMed ID: 22319005
    [Abstract] [Full Text] [Related]

  • 9. Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry.
    Lip GY, Laroche C, Popescu MI, Rasmussen LH, Vitali-Serdoz L, Dan GA, Kalarus Z, Crijns HJ, Oliveira MM, Tavazzi L, Maggioni AP, Boriani G.
    Europace; 2015 Dec 15; 17(12):1777-86. PubMed ID: 26321406
    [Abstract] [Full Text] [Related]

  • 10. Stroke risk and efficacy of apixaban in atrial fibrillation patients with moderate chronic kidney disease.
    Eikelboom JW, Connolly SJ, Gao P, Paolasso E, De Caterina R, Husted S, O'Donnell M, Yusuf S, Hart RG.
    J Stroke Cerebrovasc Dis; 2012 Aug 15; 21(6):429-35. PubMed ID: 22818021
    [Abstract] [Full Text] [Related]

  • 11. Warfarin, kidney dysfunction, and outcomes following acute myocardial infarction in patients with atrial fibrillation.
    Carrero JJ, Evans M, Szummer K, Spaak J, Lindhagen L, Edfors R, Stenvinkel P, Jacobson SH, Jernberg T.
    JAMA; 2014 Mar 05; 311(9):919-28. PubMed ID: 24595776
    [Abstract] [Full Text] [Related]

  • 12. Renal Function, Time in Therapeutic Range and Outcomes in Warfarin-Treated Atrial Fibrillation Patients: A Retrospective Analysis of Nationwide Registries.
    Bonde AN, Lip GYH, Kamper AL, Staerk L, Torp-Pedersen C, Gislason G, Olesen JB.
    Thromb Haemost; 2017 Dec 05; 117(12):2291-2299. PubMed ID: 29212117
    [Abstract] [Full Text] [Related]

  • 13. Impact of moderate to severe renal impairment on long-term clinical outcomes in patients with atrial fibrillation.
    Cho SW, Hwang JK, Chun KJ, Park SJ, Park KM, Kim JS, On YK.
    J Cardiol; 2017 Mar 05; 69(3):577-583. PubMed ID: 27236240
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The CHA2DS2-VASc score strongly correlates with glomerular filtration rate and predicts renal function decline over time in elderly patients with atrial fibrillation and chronic kidney disease.
    Beyer-Westendorf J, Kreutz R, Posch F, Ay C.
    Int J Cardiol; 2018 Feb 15; 253():71-77. PubMed ID: 29306476
    [Abstract] [Full Text] [Related]

  • 17. Relation of Renal Dysfunction to Quality of Anticoagulation Control in Patients with Atrial Fibrillation: The FANTASIIA Registry.
    Esteve-Pastor MA, Rivera-Caravaca JM, Roldán-Rabadán I, Roldán V, Muñiz J, Raña-Míguez P, Ruiz-Ortiz M, Cequier Á, Bertomeu-Martínez V, Badimón L, Anguita M, Lip GYH, Marín F, FANTASIIA Study Investigators.
    Thromb Haemost; 2018 Feb 15; 118(2):279-287. PubMed ID: 29443369
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.
    Go AS, Fang MC, Udaltsova N, Chang Y, Pomernacki NK, Borowsky L, Singer DE, ATRIA Study Investigators.
    Circulation; 2009 Mar 17; 119(10):1363-9. PubMed ID: 19255343
    [Abstract] [Full Text] [Related]

  • 20. Renal dysfunction and atrial fibrillation recurrence following cardioversion.
    Schmidt M, Daccarett M, Rittger H, Marschang H, Holzmann S, Jung P, Bojanic D, Ketteler M, Brachmann J, Rieber J.
    J Cardiovasc Electrophysiol; 2011 Oct 17; 22(10):1092-8. PubMed ID: 21489032
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.